Medicines for Smoking Cessation: Global Markets
In 2012, the global smoking cessation medicine market had an estimated value of $2.11 billion. Estimated revenues in 2013 will be $2.12 billion. The market will observe growth after 2013 with a compound annual growth (CAGR) of 3.4% to reach $2.5 billion in 2018.
- An overview of the global market for medicines used to quit smoking, which help in coping with nicotine withdrawal symptoms developed after a long-term addiction to tobacco.
- Analyses of global market trends, with data from 2011 and 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Discussion of the history and current state of smoking cessation methods, worldwide trends in smoking, and mechanisms of actions, such as nicotine replacement therapy, nicotine receptor partial agonist, and antidepressants.
- A list of pipeline products and an in-depth focus on promising pipeline candidates, as well current patents and new applications.
- Comprehensive company profiles of major players in the industry.
SCOPE OF REPORT
The report covers developed and emerging markets in order to help readers understand:
- The current state of the smoking cessation market and the key markets for its future development.
- New technologies that will influence the development of smoking cessation products.
- Market drivers and threats for the smoking cessation medicine industry.
- Major regional trends in the global smoking cessation market.
- Competitive analysis of the market.
- Branded versus generic, and over-the-counter versus prescription for nicotine replacements, non-nicotine and antidepressants.
With more than 10 years of experience with market research publishers, management consultants and government bodies, Anand Gijare specializes in predictive and exploratory research projects for market demand potential, sizing and perceptions, as well as in analyzing macro and micro markets in terms of key gaps and opportunities. His expertise includes market trends and drivers, competitive scenarios, value chain analysis and in-depth global market forecasts. He has worked on research studies across a variety of industrial sectors, including pharmaceuticals, healthcare, and information and communication technology.